JTT-551 | m-entrepreneurship.com

Product Name :
JTT-551

Search keywords :
JTT 551

drugId :
null

Target Vo:
Protein-tyrosine phosphatase 1B

Target Vo Short Name :
PTP1B

Moa_Name:
Protein-tyrosine phosphatase 1B inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Japan Tobacco (Hong Kong) Ltd

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Diabetes Mellitus, Type 2

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Mirikizumab site
S100A10 (Y10P93) Mouse mAb Cancer
AKT1/2/3 Antibody (YA633): AKT1/2/3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 56 kDa, targeting to AKT1/2/3. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts